Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donghee Kim

Showing results (131-140 of 449) with videos related to

Pageof 45
Sort By:
Journal of Biomedical Science|May 10, 2022
Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cellsDonghee Kim, Ga-Young Nam, Eunhui Seo, et al.
Plos One|August 16, 2018
Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United StatesSeung Joo Kang, Hwa Jung Kim, Donghee Kim, et al.
Clinical and Molecular Hepatology|August 27, 2024
Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortalityDonghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Annals of Internal Medicine|April 28, 2025
Trends in Mortality From Chronic Liver Disease Before, During, and After the COVID-19 Pandemic, 2015 to 2023Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
European Journal of Gastroenterology & Hepatology|March 20, 2019
Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USAKarn Wijarnpreecha, Donghee Kim, Pascale Raymond, et al.
International Journal of Molecular Sciences|September 23, 2022
Lysophosphatidic Acid Promotes Epithelial-Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic NephropathyGeon-Ho Lee, Jayeon Cheon, Donghee Kim, et al.
Alimentary Pharmacology & Therapeutics|October 15, 2025
Social Determinants of Health in Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause/Cause-Specific MortalityDonghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
European Journal of Clinical Investigation|August 28, 2023
Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortalityDonghee Kim, Richie Manikat, Anjiya Shaikh, et al.
Journal of Gastroenterology and Hepatology|May 13, 2024
Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortalityDonghee Kim, Richie Manikat, Karn Wijarnpreecha, et al.
Frontiers in Veterinary Science|June 26, 2026
Fluorometholone-antibiotic interactions in canine ocular bacteria: <i>in vitro</i> susceptibility changes in common corneal infection pathogensDonghee Kim, Ji Seung Jung, Jiwoo Park, et al.
Pageof 45

Showing results (131-140 of 449) with videos related to

Sort By:
Pageof 45
Journal of Biomedical Science|May 10, 2022
Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cellsDonghee Kim, Ga-Young Nam, Eunhui Seo, et al.
Plos One|August 16, 2018
Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United StatesSeung Joo Kang, Hwa Jung Kim, Donghee Kim, et al.
Clinical and Molecular Hepatology|August 27, 2024
Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortalityDonghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Annals of Internal Medicine|April 28, 2025
Trends in Mortality From Chronic Liver Disease Before, During, and After the COVID-19 Pandemic, 2015 to 2023Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
European Journal of Gastroenterology & Hepatology|March 20, 2019
Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USAKarn Wijarnpreecha, Donghee Kim, Pascale Raymond, et al.
International Journal of Molecular Sciences|September 23, 2022
Lysophosphatidic Acid Promotes Epithelial-Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic NephropathyGeon-Ho Lee, Jayeon Cheon, Donghee Kim, et al.
Alimentary Pharmacology & Therapeutics|October 15, 2025
Social Determinants of Health in Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause/Cause-Specific MortalityDonghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
European Journal of Clinical Investigation|August 28, 2023
Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortalityDonghee Kim, Richie Manikat, Anjiya Shaikh, et al.
Journal of Gastroenterology and Hepatology|May 13, 2024
Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortalityDonghee Kim, Richie Manikat, Karn Wijarnpreecha, et al.
Frontiers in Veterinary Science|June 26, 2026
Fluorometholone-antibiotic interactions in canine ocular bacteria: <i>in vitro</i> susceptibility changes in common corneal infection pathogensDonghee Kim, Ji Seung Jung, Jiwoo Park, et al.
Pageof 45